Stay updated on Periop mFOLFOX + Pembrolizumab in GEJ & Stomach Clinical Trial
Sign up to get notified when there's something new on the Periop mFOLFOX + Pembrolizumab in GEJ & Stomach Clinical Trial page.

Latest updates to the Periop mFOLFOX + Pembrolizumab in GEJ & Stomach Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.5.2 to v3.5.3 in the page footer. This indicates a small system/version update rather than a change to the study content.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedFooter revision indicator updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedRevision v3.5.0 has been added. Revision v3.4.3 has been removed.SummaryDifference0.1%

- Check56 days agoChange DetectedPage revision label updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check77 days agoChange DetectedAdded 'Gastric cancer' as a condition/topic and included a resources entry for Genetic and Rare Diseases Information Center related to gastric cancer.SummaryDifference0.2%

- Check84 days agoChange DetectedThe page shows an administrative Revision: v3.4.2 and removal of a general funding/status notice (including Revision: v3.4.1), which do not affect the study content or results; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Periop mFOLFOX + Pembrolizumab in GEJ & Stomach Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Periop mFOLFOX + Pembrolizumab in GEJ & Stomach Clinical Trial page.